BSHS 496 - Rare Disorders and Specialty Pharmaceuticals (RDSP)

Min Units: 2
Max Units: 2
Recent innovations in biotechnology research and changes in regulatory policy have increased the market for specialty pharmaceuticals that are often used to treat rare, chronic diseases. The specialty market and related job opportunities are increasing rapidly. This is also disrupting the health care system as a whole including insurance design, benefit management, and practice management. This course will explore the social, economic, and administrative impact of rare disease and specialty pharmaceuticals while exploring different rare diseases and treatments as scenarios to apply learning. (U) Fall
Prerequisite(s): BSHS 230 and RX 400